Impact of Diet on Cognitive Ability in Older Adults

Alzheimer’s Disease Overview

Alzheimer’s disease currently affects nearly 50 million individuals globally, a figure projected to increase to 115 million by 2050. This condition is the leading cause of dementia, often starting with mild memory loss and advancing to a stage where individuals lose the ability to interact with their surroundings. Despite extensive research, the causes of Alzheimer’s remain largely unclear, and effective treatments or preventive measures are still elusive.

As Alzheimer’s progresses, patients experience a decline in synaptic connections between neurons, which impairs memory. Additionally, chronic inflammation in the nervous system may contribute to the disease’s development, potentially linked to the body’s response to gut microbes. Studies indicate that individuals with Alzheimer’s exhibit elevated levels of gut bacteria associated with inflammation.

Research Study on Dietary Interventions

A recent study conducted by researchers at Wake Forest School of Medicine, published in eBioMedicine, explored the effects of the modified Mediterranean-ketogenic diet (MMKD) on the gut microbiome of Alzheimer’s patients compared to the American Heart Association Diet.

The MMKD is a variation of the ketogenic diet that permits higher carbohydrate intake than traditional keto diets, allowing for increased consumption of vegetables, fruits, healthy fats, and proteins, particularly from sources such as olive oil and fish. Conversely, the American Heart Association Diet emphasizes low-fat intake, focusing on fruits, vegetables, whole grains, low-fat dairy, and lean protein sources like nuts and lean meat.

Study Design and Findings

The study involved 17 participants at risk for Alzheimer’s disease, with 11 diagnosed with mild cognitive impairment (MCI). Participants were randomly assigned to either the MMKD or the American Heart Association Diet for six weeks. Following this period, they returned to their normal diets for another six weeks, after which they switched to the alternate diet for the final six weeks.

At the study’s outset, after the first six weeks, and at the conclusion of the final six weeks, participants underwent spinal taps, and stool and blood samples were collected. Throughout the study, participants maintained food diaries and had their blood sugar levels monitored weekly to ensure adherence to their dietary plans.

Analysis of the collected data revealed specific bacterial families within the gut microbiome of MCI participants, some of which are linked to inflammation. The findings indicated that the MMKD may offer benefits for those with MCI, notably reducing levels of compounds associated with impaired short-term memory.

Future Research Directions

Further investigation over extended periods and with larger participant groups is needed to validate these findings. Researchers are optimistic that the study has identified potential markers for MCI that could lead to Alzheimer’s disease, establishing a significant correlation between diet and cognitive health.

Conclusion

This study contributes to the understanding of how dietary choices may influence cognitive function in older adults, highlighting the potential role of the gut microbiome in Alzheimer’s disease progression.

References

Nagpal R, Neth B, Wang S, Craft S, Yadav H. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer’s disease markers in subjects with mild cognitive impairment. EBioMedicine. 2019;47:529-542. doi:10.1016/j.ebiom.2019.08.032

Image by Deborah Breen Whiting from Pixabay